The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation

Kimberly N. Smitheman, Tesa M. Severson, Satyajit R. Rajapurkar, Michael T. McCabe, Natalie Karpinich, James Foley, Melissa B. Pappalardi, Ashley Hughes, Wendy Halsey, Elizabeth Thomas, Christopher Traini, Kelly E. Federowicz, Jenny Laraio, Fredrick Mobegi, Geraldine Ferron-Brady, Rabinder K. Prinjha, Christopher L. Carpenter, Ryan G. Kruger, Lodewyk Wessels, Helai P. MohammadDaniel J. Hodson, Michael Screen, Martin Turner, Andreas Greinacher, Julia J.M. Eekels, Mitchell S. Cairo, Auke Beishuizen, Yaya Chu, Aliza Gardenswartz, Amanda M. Termuhlen, Mitchell S. Cairo, M. Frenquelli, N. Caridi, E. Antonini, F. Storti, V. Viganò, M. Gaviraghi, M. Occhionorelli, S. Bianchessi, L. Bongiovanni, A. Spinelli, M. Marcatti, D. Belloni, E. Ferrero, S. Karki, P. Brambilla, F. Martinelli-Boneschi, S. Colla, M. Ponzoni, R. A. DePinho, G. Tonon, Elena Armenteros-Monterroso, Lu Zhao, Luca Gasparoli, Tony Brooks, Kerra Pearce, Marc R. Mansour, Joost H. A. Martens, Jasper de Boer, Owen Williams, Sophia Adamia, Ivane Abiatari, Samir B. Amin, Mariateresa Fulciniti, Stephane Minvielle, Cheng Li, Philippe Moreau, Herve Avet-Loiseau, Nikhil C. Munshi, Kenneth C. Anderson, Linus Angenendt, Eike Bormann, Caroline Pabst, Vijay Alla, Dennis Görlich, Leonie Braun, Kim Dohlich, Christian Schwöppe, Stefan K Bohlander, Maria Francisca, Arteaga Klaus, Wolfgang Hartmann, Adrian Angenendt, Torsten Kessler, Rolf M Mesters, Matthias Stelljes, Bob Löwenberg, Hubert Serve, Carsten Müller-tidow Georg, Lenz Bernhard, M Christina Sauerland, Wolfgang Hiddemann, Wolfgang E Berdel, Utz Krug, Klaus H Metzeler, Jan-henrik Mikesch Tobias Herold, Christoph Schliemann, Tobias Herold, Ayalew Tefferi, Paola Guglielmelli

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)

Abstract

Molecular causes of many inherited platelet disorders have been unraveled. Next generation sequencing facilitates diagnosis in 30-50% of patients. However, interpretation of genetic variants is challenging and requires careful evaluation in the context of the patient's phenotype. Before detailed testing is initiated, the treating physician and the patient should be aware why testing is performed and should agree on the consequences it may have, especially before testing for variants in genes associated with an increased risk for hematologic malignancies.
Original languageEnglish
Pages (from-to)1021-1042
Number of pages22
JournalLeukemia
Publication statusPublished or Issued - Feb 2019

Keywords

  • B-cell non-Hodgkin lymphoma
  • Childhood
  • IL-15 superagonist
  • adolescent
  • cellular immunotherapy
  • chimeric antigen receptor
  • current perspectives
  • non-Hodgkin lymphoma
  • stem cell transplantation
  • young adult

Cite this